16-84170218-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_178452.6(DNAAF1):c.1390C>T(p.Pro464Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000868 in 1,612,000 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_178452.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAAF1 | NM_178452.6 | c.1390C>T | p.Pro464Ser | missense_variant | 8/12 | ENST00000378553.10 | NP_848547.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAAF1 | ENST00000378553.10 | c.1390C>T | p.Pro464Ser | missense_variant | 8/12 | 1 | NM_178452.6 | ENSP00000367815 | P1 | |
DNAAF1 | ENST00000563818.5 | n.1067C>T | non_coding_transcript_exon_variant | 4/8 | 2 | |||||
DNAAF1 | ENST00000570298.5 | n.1544C>T | non_coding_transcript_exon_variant | 8/11 | 2 | |||||
DNAAF1 | ENST00000563093.5 | c.1226-24C>T | intron_variant, NMD_transcript_variant | 2 | ENSP00000457373 |
Frequencies
GnomAD3 genomes AF: 0.0000199 AC: 3AN: 151082Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251098Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135794
GnomAD4 exome AF: 0.00000685 AC: 10AN: 1460802Hom.: 0 Cov.: 95 AF XY: 0.00000963 AC XY: 7AN XY: 726768
GnomAD4 genome AF: 0.0000265 AC: 4AN: 151198Hom.: 0 Cov.: 32 AF XY: 0.0000271 AC XY: 2AN XY: 73918
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 24, 2021 | This sequence change replaces proline with serine at codon 464 of the DNAAF1 protein (p.Pro464Ser). The proline residue is weakly conserved and there is a moderate physicochemical difference between proline and serine. This variant is present in population databases (rs566279701, ExAC 0.01%). This variant has not been reported in the literature in individuals affected with DNAAF1-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at